Log in to save to my catalogue

Anti-EGFL7 antibodies enhance stress-induced endothelial cell death and anti-VEGF efficacy

Anti-EGFL7 antibodies enhance stress-induced endothelial cell death and anti-VEGF efficacy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3754254

Anti-EGFL7 antibodies enhance stress-induced endothelial cell death and anti-VEGF efficacy

About this item

Full title

Anti-EGFL7 antibodies enhance stress-induced endothelial cell death and anti-VEGF efficacy

Publisher

United States: American Society for Clinical Investigation

Journal title

The Journal of clinical investigation, 2013-09, Vol.123 (9), p.3997-4009

Language

English

Formats

Publication information

Publisher

United States: American Society for Clinical Investigation

More information

Scope and Contents

Contents

Many oncology drugs are administered at their maximally tolerated dose without the knowledge of their optimal efficacious dose range. In this study, we describe a multifaceted approach that integrated preclinical and clinical data to identify the optimal dose for an antiangiogenesis agent, anti-EGFL7. EGFL7 is an extracellular matrix-associated pro...

Alternative Titles

Full title

Anti-EGFL7 antibodies enhance stress-induced endothelial cell death and anti-VEGF efficacy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3754254

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3754254

Other Identifiers

ISSN

0021-9738

E-ISSN

1558-8238

DOI

10.1172/JCI67892

How to access this item